EXOZYMES INC. — Director's Dealing 2024

Nov 19, 2024

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Invizyne Technologies Inc (IZTC)
CIK: 0002010788
Period of Report: 2024-11-08

Reporting Person: HAYAT MOHAMMAD (Director, President & Chairman of Board)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	155818	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options for Common Stock	$2.44	2028-01-31	Common Stock (311636)		Direct
Restricted Stock Grant for Common Stock	$2.44	2031-07-17	Common Stock (82118)		Direct
Restricted Stock Grant for Common Stock	$2.44	2032-03-25	Common Stock (102647)		Direct
Restricted Stock Grant for Common Stock	$3.32	2033-04-28	Common Stock (37747)		Direct

Footnotes

F1: Vest at the rate of 5,194 shares per month, commencing on February 1, 2021, and become exercisable once vested. The options will be fully vested on January 31, 2026.

F2: The shares underlying the grant vest in full once issued.